medigraphic.com
Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular

2016, Number 2

<< Back Next >>

Rev Mex Angiol 2016; 44 (2)

Sarcoma sinovial monofásico epiteloide en extremidad torácica, como diagnóstico diferencial de pseudoaneurisma trombosado: reporte de un caso del Hospital General de México “Dr. Eduardo Liceaga”

Flores-Aguilar SR, Lecuona-Huet N, Córdova-Quintal P, Lacay-Valenzuela ME, Cárdenas-Sánchez ÁM

Language: Spanish
References: 12
Page: 77-80
PDF size: 155.53 Kb.


ABSTRACT

The most common cause of pseudoaneurysm (PA) is post-punction due to endovascular procedures, blunt vascular trauma has a low incidence, 0.6-1.14%, being more frequent in men. Clinically is embodied with several signs and symptoms. There by it has to set differential diagnostic with soft tissue tumors. Soft tissue sarcoma are a group of heterogeneous neoplasm, synovial sarcoma is rare, affect the inferior extremities more frequently than superior. Main clinical manifestation is a mass that increase pretty fast of size. We report a case of SS in thoracic extremity with clinical manifestation like a posttraumatic pseudoaneurysm. A monophasic epiteloid tumor was diagnosed with histology and immunohistochemistry. Although extremely rare, SS should be considered in the differential diagnosis of posttraumatic pseudoaneurysm.


REFERENCES

  1. Pastor GM, Rivera MR. Traumatismos vasculares de los miembros, diagnóstico y tratamiento actual. Angiología 2007; 59(Supl. 2): S39-S52.

  2. Wibmer C, Leithner A, Zielonke N, et al. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol 2010; 21(5): 1106-11.

  3. Bijwaard KE, Fetsch JF, Przygodzki R, Taubenberger JK, Lichy JH. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase- polymerase chain reaction. J Mol Diagn 2002; 4(1): 59-64.

  4. Hayashi Y. Recent progress of molecular diagnosis in pediatric malignancies. Gan To Kagaku Ryoho 2003; 30(9): 1211-24.

  5. Chan JA, McMenamin ME, Fletcher CD. Synovial sarcoma in older patients: clinicopathological analysis of 32 cases with emphasis on unusual histological features. Histopathology 2003; 43(1): 72-83.

  6. American Joint Committee on Cancer. Soft tissue sarcoma. In: American Joint Committee on Cancer Staging Manual. 7th Ed. New York: Springer; 2010: 291-6.

  7. Weiss SW, Goldblum JR. Malignant soft tissue tumors of uncertain type. En: Strauss M (ed.). Enzinger and Weiss’s Soft Tissue Tumors. 4a ed. St. Louis, Missouri: Mosby; 2001, p. 1483-571.

  8. Herrera A, Granados M. Manual de Oncología. Procedimientos médico-quirúrgicos. 5a Ed. McGraw Hill, 2013.

  9. Pelmus M, Guillou L, Hostein I, Sierankowski G, Lussan C, Coindre JM. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am J Surg Pathol 2002; 26: 1434-40.

  10. Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression. Am J Surg Pathol 2007; 31(2): 240-6.

  11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™. Soft tissue sarcoma. V1.2011. Available at: http://www.nccn.org [Accessed 25.02.11].

  12. Goldberg JM. Immunotherapy of sarcomas. Department of Pediatrics, University of Miami Miller School of Medicine and Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA. Curr Opin Oncol 2013; 25: 390-7.




2020     |     www.medigraphic.com